•
Jun 30, 2013

Abeona Therapeutics Q2 2013 Earnings Report

EPS
$0.03
Previous year: -$0.46
-106.5%
Cash and Equivalents
$1.8M
Previous year: $588K
+205.8%
Free Cash Flow
$1.74M
Previous year: -$777K
-323.6%
Total Assets
$2.4M
Previous year: $2.44M
-1.6%

Abeona Therapeutics

Abeona Therapeutics